(Q50983366)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17559342%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

editorial

0 references

title

Genetic engineering cures mice of neurological deficits: prospects for treating Angelman syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17559342%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17559342%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Ype Elgersma

series ordinal

1

1 reference

26 March 2018

http://europepmc.org/abstract/MED/17559342

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17559342%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17559342%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17559342%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17559342%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

539-541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17559342%20AND%20SRC:MED&resulttype=core&format=json

The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Reversal of neurological defects in a mouse model of Rett syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Neurological aspects of the Angelman syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Mouse genetic approaches to investigating calcium/calmodulin-dependent protein kinase II function in plasticity and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Calcium/calmodulin-dependent protein kinase II and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Inhibitory autophosphorylation of CaMKII controls PSD association, plasticity, and learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

A previously unrecognised phenotype characterised by obesity, muscular hypotonia, and ability to speak in patients with Angelman syndrome caused by an imprinting defect

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.539

21 January 2018

Identifiers

DOI

10.2217/14622416.8.6.539

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17559342%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference